By Frank Prenesti
Date: Thursday 23 Feb 2023
(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.
Currency | US Dollars |
Share Price | $ 118.28 |
Change Today | $ -0.74 |
% Change | -0.62 % |
52 Week High | $120.47 |
52 Week Low | $72.73 |
Volume | 2,337,613 |
Shares Issued | 1,246.00m |
Market Cap | $147,377m |
RiskGrade | 120 |
Strong Buy | 10 |
Buy | 11 |
Neutral | 6 |
Sell | 1 |
Strong Sell | 0 |
Total | 28 |
Time | Volume / Share Price |
12:41 | 100 @ $118.28 |
12:41 | 100 @ $118.28 |
12:41 | 100 @ $118.28 |
12:41 | 200 @ $118.28 |
12:41 | 100 @ $118.28 |
You are here: research